Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_assertion description "[Here, we demonstrate that for one patient, with the first reported fibroblast growth factor receptor 2 (FGFR2) fusion transcript in ovarian cancer, circulating tumor DNA (ctDNA) is a more sensitive and specific biomarker than CA125, and it can also inform on a candidate therapeutic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_assertion evidence source_evidence_literature NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_assertion SIO_000772 24563622 NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_assertion wasDerivedFrom befree-20150227 NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_assertion wasGeneratedBy ECO_0000203 NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP962783.RAu_0cbR9z_HcXxBpxeEzSJAzQAVTPTnMPz1dWntNTAG4130_provenance.